Balloon angioplasty of arteries of the upper extremities in patients with extracranial giant-cell arteritis

Ann Rheum Dis. 2006 Sep;65(9):1124-30. doi: 10.1136/ard.2005.048470. Epub 2006 Feb 7.

Abstract

Objectives: To evaluate the outcome of balloon angioplasty in the arteries of the upper extremities in patients with giant-cell arteritis (GCA) and stenosing extracranial involvement.

Methods: Percutaneous transluminal angioplasty (PTA) for symptomatic upper limb artery stenoses (n = 29) and occlusions (n = 1) resistant to medical treatment was carried out in 10 patients (all women, mean age 65 years) with GCA. Vascular lesions were located in the subclavian (n = 4), axillary (n = 10) and brachial (n = 16) arteries. Interventional treatment was accompanied by immunosuppressive drugs in all patients. Follow-up included clinical and serological examination, magnetic resonance angiography and colour duplex ultrasound.

Results: Initial technical success of angioplasty was achieved in the case of all vascular lesions. In five patients, marked recurrent stenoses (vascular territories; n = 10/30) were found during follow-up (mean 24 months). The cumulative primary patency rate was 65.2%. All recurrent lesions developed in the territories of the initial long-segment stenoses. Repeated PTA (vascular territories, n = 8; patients, n = 5) provided a cumulative secondary patency rate of 82.6% and a cumulative tertiary patency rate of 89.7%.

Conclusions: Despite a tendency to restenoses, balloon angioplasty of the upper-extremity artery, in combination with immunosuppressive treatment, is an efficient method for the treatment of extracranial GCA.

Publication types

  • Evaluation Study

MeSH terms

  • Aged
  • Angioplasty, Balloon / methods*
  • Arterial Occlusive Diseases / diagnostic imaging
  • Arterial Occlusive Diseases / etiology
  • Arterial Occlusive Diseases / therapy*
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Giant Cell Arteritis / complications
  • Giant Cell Arteritis / diagnostic imaging
  • Giant Cell Arteritis / therapy*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Middle Aged
  • Radiography
  • Recurrence
  • Treatment Outcome
  • Upper Extremity / blood supply*
  • Vascular Patency

Substances

  • Immunosuppressive Agents